EUVIMEDEUVIMED entdecken
Crossref

Magnetic-Optical Dual-Modality Imaging Monitoring Oxaliplatin through the Crystalline Mn-Metal–Organic Framework Sensor

Yanqiu Chen, Xingai Ge, Fang Fang, Jia Wang, Zijia Wang, Kun Qian iD, Hongshan Zhong, Yu Sun

ACS Sensors · 24.07.2026 · 11 (7) · 5646-5661

DOI: 10.1021/acssensors.6c00114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 13.07.2026. Verfasst von Yanqiu Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Radiology department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou121001, P. R. China. Hauptthemen laut MEDLINE: Oxaliplatin, Manganese, Magnetic Resonance Imaging, Antineoplastic Agents. Die Arbeit nennt 95 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province, Department of Education of Liaoning Province, Liaoning Revitalization Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To support image-assisted evaluation of anticancer drugs in biological settings, functional sensing materials are needed to integrate sensitive molecular detection with imaging-compatible readouts. Oxaliplatin (OHP) is widely used in chemotherapy, and accurate OHP assessment in biological matrices remains important for dosage optimization and toxicity management. Herein, a nanosized Mn-MOF was prepared as a fluorescence sensor and MRI-responsive platform for OHP-associated detection. The structure, morphology, elemental distribution, and Mn surface electronic state of the Mn-MOF were characterized by XRD, SEM, AFM, EDS mapping, XPS, and DLS. Mn-MOF showed limited dialyzable Mn leakage, and retained fluorescence stability and MRI signal stability during 28 days of storage. As a T1 MRI contrast platform, Mn-MOF exhibited a longitudinal relaxivity (r1) of 6.38 mM–1 s–1 at 3.0 T and showed OHP-dependent T1 signal attenuation over the tested OHP concentration range of 0.5–10 mM. Preliminary in vivo MRI experiments showed liver and kidney T1 enhancement after intravenous Mn-MOF administration and OHP-associated attenuation of the Mn-MOF-enhanced signal. In fluorescence mode, the Mn-MOF nanosensor exhibited concentration-dependent quenching toward OHP in ultrapure water over 0.33 fM–18.2 μM, with a calibration-model-based estimated limit of detection (LOD) of 41.1 aM under the stated Mn-MOF-assisted fluorescence sensing conditions. The sensor also showed selectivity under the tested interference conditions, spiked-rabbit-serum calibration and recovery performance, and 28-day fluorescence response stability. Hemolysis, H&E staining, KGN and HK-2 cell-viability assays indicated preliminary hemocompatibility and cytocompatibility under the tested conditions. This dual-modal design provides a preliminary strategy for integrating optical OHP sensing with MRI readout in a single Mn-MOF platform.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinManganeseMagnetic Resonance ImagingAntineoplastic AgentsOptical ImagingAnimalsHumansFluorescent Chemosensor CompoundsMiceContrast Media

Stichwörter der Autor:innen

multimodal detectionnanosized Mn-MOFnoble-metal-free materialprecise analysis of anti-cancer drugsrapid response sensor

Substanzen

OxaliplatinManganeseAntineoplastic AgentsFluorescent Chemosensor CompoundsContrast Media

Autor:innen und Institutionen

  • Radiology department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou121001, P. R. China.
  • Jinzhou Medical University , Jinzhou121001, P. R. China.
  • Department of Interventional Radiology, The First Hospital of China Medical University, No. 155 Nanjing North Street, Shenyang110001, LiaoningP. R. China.

ORCID-Profile: Kun Qian

Förderung

  • Natural Science Foundation of Liaoning Province
  • Department of Education of Liaoning Province
  • Liaoning Revitalization Talents Program
  • Liaoning Provincial Professional Technology Innovation Center of Medical Effects and Quality Evaluation

Zitieren

APA

Chen, Y., Ge, X., Fang, F., Wang, J., Wang, Z., Qian, K., Zhong, H., & Sun, Y. (2026). Magnetic-Optical Dual-Modality Imaging Monitoring Oxaliplatin through the Crystalline Mn-Metal–Organic Framework Sensor. ACS Sensors, 11(7), 5646-5661. https://doi.org/10.1021/acssensors.6c00114

Vancouver

Chen Y, Ge X, Fang F, Wang J, Wang Z, Qian K, et al. Magnetic-Optical Dual-Modality Imaging Monitoring Oxaliplatin through the Crystalline Mn-Metal–Organic Framework Sensor. ACS Sensors. 2026;11(7):5646-5661. doi:10.1021/acssensors.6c00114

BibTeX
@article{Chen2026,
  author = {Chen, Yanqiu and Ge, Xingai and Fang, Fang and Wang, Jia and Wang, Zijia and Qian, Kun and Zhong, Hongshan and Sun, Yu},
  title = {Magnetic-Optical Dual-Modality Imaging Monitoring Oxaliplatin through the Crystalline Mn-Metal–Organic Framework Sensor},
  journal = {ACS Sensors},
  year = {2026},
  volume = {11},
  number = {7},
  pages = {5646--5661},
  doi = {10.1021/acssensors.6c00114}
}
Kostenlos starten →